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Editor: D. BarceloIt is essential to monitor the release of organic micropollutants from wastewater treatment plants (WWTPs) for
developing environmental risk assessment and assessing compliancewith legislative regulation. In this study the
impact of sampling strategy on the quantitative determination ofmicropollutants in efﬂuent wastewaterwas in-
vestigated. An extended list of 90 chiral and achiral micropollutants representing a broad range of biological and
physico-chemical properties were studied simultaneously for the ﬁrst time. During composite sample collection
micropollutants can degrade resulting in the under-estimation of concentration. Cooling collected sub-samples
to 4 °C stabilised ≥81 of 90micropollutants to acceptable levels (±20% of the initial concentration) in the studied
efﬂuents. However, achieving stability for all micropollutants will require an integrated approach to sample col-
lection (i.e., multi-bottle samplingwithmore than one stabilisationmethod applied). Full-scale monitoring of ef-
ﬂuent revealed time-paced composites attained similar information to volume-paced composites (inﬂuent
wastewater requires a sampling mode responsive to ﬂow variation). The option of monitoring efﬂuent using
time-paced composite samplers is advantageous as not all WWTPs have ﬂow controlled samplers or suitable
sites for deploying portable ﬂowmeters. There has been little research to date on the impact of monitoring strat-
egy on the determination of chiral micropollutants at the enantiomeric level. Variability in wastewater ﬂow re-
sults in a dynamic hydraulic retention time within the WWTP (and upstream sewerage system). Despite chiral
micropollutants being susceptible to stereo-selective degradation, no diurnal variability in their enantiomeric
distribution was observed. However, unused medication can be directly disposed into the sewer network creat-
ing short-term (e.g., daily) changes to their enantiomeric distribution. As enantio-speciﬁc toxicity is observed in
the environment, similar resolution of enantio-selective analysis to more routinely applied achiral methods is
needed throughout the monitoring period for accurate risk assessment.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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The presence and possible impact of municipally derived organic
micropollutants in the environment is of increasing concern. Several
micropollutants have been recommended for inclusion in a watch list
under the Water Framework Directive (2000/60/EC) (Carvalho et al.,
2015). This includes diclofenac, estrone, 17β-estradiol, 17α-
ethinylestradiol, erythromycin, clarithromycin, and azithromycin.
Diclofenac, 17β-estradiol and 17α-ethinylestradiol have proposed Envi-
ronmental Quality Standards (EQS, expressed as annual average) of 100,
0.4 and 0.035 ng L−1, respectively (European Commission, 2012). Con-
sequently, it is expected that legislation will be implemented to govern
the discharge of these types of micropollutants from wastewater treat-
ment plants (WWTPs) into the environment. Developing environmen-
tal legislation is underpinned by robust monitoring data-sets and
accurate risk assessment. However, such data-sets (previously limited
by analytical capabilities) are currently lacking due to inadequate sam-
pling protocols.
Composite sampling is usually applied to obtain average
micropollutant concentrations over 24 h. An uncertainty associated
with this approach is the loss of micropollutants during sample collec-
tion (McCall et al., 2016). Micropollutants could be lost due to sorption
onto sampler bottles. Polypropylene is considered themost widely used
sampler bottle material, yet there is a paucity of information published
in the literature on the loss of micropollutants fromwater to its surface.
Micropollutants can also be degraded by bacteria present within the
wastewater matrix (Hillebrand et al., 2013). Cooling sub-samples to
4 °C, adjusting to pH 2 and adding sodium azide have all been suggested
to improve stability (Baker and Kasprzyk-Hordern, 2011; Vanderford et
al., 2011; Hillebrand et al., 2013). To date these different stabilisation
methods have not been challenged with a high number of
micropollutants (N50), representing a broad range of biological and
physico-chemical properties. Ideally, a generic stabilisation method
could be established for the multi-residue determination of
micropollutants in wastewaters.
Ort et al. (2010) showed that collecting a time proportional compos-
ite samplewith a sampling frequency of ≤20min can give inaccurate/bi-
ased results in inﬂuent wastewater for some micropollutants. This was
established through a modelling study which found a composite sam-
pling approach that is responsive to variations in wastewater ﬂow
(ﬂow or volume proportional) is needed to give unbiased information
(depending on the sampling frequency and number of toilet ﬂushes or
‘pulses’ (p) expected per micropollutant in the catchment each day)
(Ort et al., 2010). It is currently unknown whether these observations
are applicable to efﬂuent wastewater. Mixing within the WWTP will
provide a more uniform ﬂow and concentration proﬁle. On the other
hand thismay be counteracted by variability inmicropollutant degrada-
tion due to dynamic wastewater ﬂow and secondary treatment hydrau-
lic retention time (HRT) (Majewsky et al., 2011). This is essential to
investigate to ensure current sampling practices of efﬂuent wastewater
obtain accurate concentration information. Not allWWTPs have perma-
nently deployed ﬂow dependent samplers (particularly at smaller sites
serving a population of ≤100,000), and rely on portable time dependent
samplers for monitoring micropollutants. To date, there is a paucity of
information on the impact of active sampling mode to the quantitative
determination of micropollutants in efﬂuent wastewater.
Obtaining accurate information on the enantiomeric distribution of
chiral micropollutants is essential for accurate environmental risk as-
sessment and needs incorporated into monitoring strategies (Petrie et
al., 2014). Enantiomers of the same chiral micropollutant can exert dif-
ferent toxicological responses to exposed aquatic species (Stanley et al.,
2007; De Andrés et al., 2009). However, little is known of the temporal
variability in enantiomeric distribution of chiral micropollutants in ef-
ﬂuent during a typical one-week monitoring period. As many chiral
micropollutants undergo stereo-selective degradation, enantiomeric
distribution could change with varying in-sewer and WWTP HRT.Such inﬂuences are expected to be compound speciﬁc as different chiral
micropollutants undergo varying degrees of stereo-selectivitywhen ex-
posed to environmental conditions (Kasprzyk-Hordern and Baker,
2012).
The aim of this studywas to evaluate the impact ofmonitoring strat-
egy on the quantitative determination of micropollutants in efﬂuent
wastewater. This will help inform the design of future environmental
monitoring studies for improved data quality to improve risk assess-
ment and assess compliance to environmental regulation. The objec-
tives of the study were to:
i. Assess the behaviour of 90 micropollutants during composite sam-
ple collection using a range of stabilisation methods
ii. Compare grab sampling, and volume- and time- paced composite
sampling for the determination of micropollutants in efﬂuent with
a wide range of expected pulses
iii. Evaluate diurnal changes in enantiomeric distribution of chiral
micropollutants in efﬂuent wastewater
A total of 90micropollutants representing a broad range of biological
and physico-chemical propertieswere studied (Table S1), andboth con-
centration and EF (where possible) were determined. This is the ﬁrst
study which has investigated the impact of sampling strategy on such
a high number of diverse micropollutants (including enantiomerism)
simultaneously in efﬂuent. Equivalent studies were also conducted in
inﬂuent wastewater for comparison purposes and full ﬁndings of
these can be found in Supplementary Material.
2. Materials and methods
2.1. Materials
Information on studied micropollutants are detailed in Table S1. In-
ternal standards acetaminophen-D4, ibuprofen-D3, bisphenol A-D16,
carbamazepine-13C6, ketoprofen-D3, naproxen-D3, sertraline-D3, ta-
moxifen 13C2 15N, propranolol-D7, atenolol-D5 and metformin (di-
methyl-D6) were purchased from Sigma-Aldrich (Gillingham, UK).
Bezaﬁbrate-D6 was obtained from QMX laboratories (Thaxted, UK).
Methylparaben-13C, amphetamine-D5, methamphetamine-D5,
MDMA-D5, 3,4-methylenedioxy-amphetamine-D5 (MDA-D5), heroin-
D9, codeine-D6, ketamine-D4, cocaine-D3, benzoylecgonine-D8, 2-
ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine-D3 (EDDP-D3), mor-
phine-D3, cotinine-D3, cocaethylene-D8, temazepam-D5, 1S,2R-(+)-
ephedrine-D3, mephedrone-D3, methadone-D9, norketamine-D4, es-
trone (2,4,16,16-D4), estradiol (2,4,16,16-D4) and quetiapine-D8
hemifumurate were purchased from LGC standards (Middlesex, UK).
Citalopram-D6, metoprolol-D7, ﬂuoxetine-D5 and mirtazapine-D3
were obtained from TRC (Toronto, Canada). Methanol (MeOH) and tol-
uene was HPLC grade and purchased from Sigma-Aldrich. Water (H2O)
was of 18.2 MΩ quality (Elga, Marlow, UK). All glassware was
deactivated using 5% dimethylchlorosilane (DMDCS) in toluene
(Sigma–Aldrich). Ammonium acetate (NH4OAc), ammonium ﬂuoride,
sodium azide (NaN3), ammonium hydroxide (NH4OH), hydrochloric
acid (HCl), formic acid (HCOOH) and acetic acid (1.0 M) were pur-
chased from Sigma-Aldrich (Gillingham, UK). Oasis HLB (60 mg, 3 mL)
solid phase extraction (SPE) cartridges were purchased from Waters
(Manchester, UK).
2.2. Analytical methods
Brieﬂy, samples for SPE were brought to room temperature, ﬁltered
(GF/F 0.7 μm glass ﬁbre) and 50mL aliquots spiked with 50 ng of all in-
ternal standards. These were loaded onto pre-conditioned Oasis HLB
cartridges, dried and eluted using 4 mL MeOH. If SPE cartridges were
frozen prior to elution, they were eluted and analysed within one
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in 500 μL 80:20 H2O:MeOH. Samples for analysis by direct injection
were ﬁltered, spiked with the internal standard mix and adjusted with
MeOH to achieve 80:20 H2O:MeOH. Prepared samples were then
analysed for 90 micropollutants using a fully validated ultra-high-per-
formance liquid chromatography tandem mass spectrometry method-
ology using a Waters Acquity UPLC system (Manchester, UK) coupled
to a Xevo TQD Triple Quadrupole Mass Spectrometer (Waters, Man-
chester, UK). Two separate chromatography runs were applied to
achieve maximum sensitivity of both acidic and basic micropollutants.
A full description of the method is available in Petrie et al. (2016b)
(Table S2). Method recoveries in wastewaters ranged from 40 to 152%
andmethod precisionwas b10% for themajority of studied compounds.
Samples for enantio-selective analysis were ﬁltered, spiked with ra-
cemic mixtures of selected internal standards and subject to SPE as de-
scribed above. Dried extracts were then reconstituted in 500 μL of the
appropriatemobile phase. For enantiomeric separation of beta-blockers
and anti-depressants, a Chirobiotic V column (100 × 2mm; 5 μm inter-
nal diameter)with amobile phase consisting of 4mMNH4OAc inMeOH
containing 0.005% HCOOH was used. The method is described in detail
in Evans et al. (2015) (Table S2). For separation of amphetamine-like
compounds a Cellobiohydrolase column (100 × 2mm, 5 μm internal di-
ameter) and a mobile phase consisting 1 mM NH4OAc in 85:15
H2O:MeOH. A full description of the method is available in
Castrignanò et al. (2016) (Table S2).
EFs were calculated according to Eq. (1):
EF ¼ E þð Þ
E þð Þ þ E −ð Þ½  ð1Þ
Where EF is the enantiomeric fraction, E(+) is the peak area of the (+)
enantiomer corrected for the deuterated internal standard response and
E(−) is the peak area of the (−) enantiomer corrected for the deuterat-
ed internal standard response.
Total and dissolved organic carbon were measured using TOC-VCPN
Total Organic Carbon Analyser TOC-VCPH/CPN (Shimadzu, Milton Keynes,
UK). Suspended solids were measured according to standard methods
(APHA, 1998).
2.3. Wastewater treatment works
TheWWTP under investigation (WWTP A) is located in South-West
England with a population equivalent (PE) of 105,847. The process
consisted of primary screens and grit removal, followed by conventional
primary sedimentation, trickling ﬁlters and ﬁnal sedimentation in
humus tanks. The majority of receiving wastewater is pumped from a
sewage pumping station located 8 km from theWWTP. Sub-catchments
are pumped from the station intermittently with separate pumps oper-
ating for anhour at a time. Typically, a single pump is in operation all the
time except in the early hours of the morning during periods of low
ﬂow. Under normal ﬂow conditions, wastewater takes from b30 min
to 6 h to reach theWWTP from the point of entry in thewastewater sys-
tem. Wastewater was also collected from a second WWTP (WWTP B)
located in South-West England to investigate micropollutant stability.
This has a PE of 909,617 and differed from WWTP A in the biological
treatment utilised. Here, sequencing batch reactors (activated sludge)
were used.
2.4. Laboratory stability studies
Hourly composite samples (100 mL every 5 min to help account for
short-term variability in wastewater composition) of wastewater were
collected fromWWTPA andB in polypropylene bottles to assess the sta-
bility of micropollutants in collected samples. Wastewater was
transported to the laboratory on ice andwithin 1 h of collection. The ap-
plied methodology to test micropollutant stability was similar to thatdescribed by Hillebrand et al. (2013). One litre samples were spiked at
room temperaturewith an additional 1000 ng L−1 of allmicropollutants
and mixed continuously for 30 min using a magnetic stirrer. 10 mL ali-
quotswere then collected for SPE extraction (time 0) and the remaining
sample separated equally into six polypropylene 1 L bottles. Two bottles
were adjusted to pH 2 using HCl, two had NaN3 added to achieve a con-
centration of 1 g L−1 and two were left untreated. Bottles were then
stored in the dark at 18 °C and 4 °C and left unmixed for 24 h. Duplicate
samples (10 mL aliquots used for SPE in this case) were then prepared
for analysis as described in Section 2.2. Samples previously adjusted to
pH2were re-adjusted to pH7.5withNH4OHandmixed for an addition-
al 30 min prior to SPE. To assess the loss of micropollutants to polypro-
pylene sampler containers, deionised water was spiked with all
micropollutants (1000 ng L−1). These were then subject to SPE as de-
scribed above at time 0 and following 24 h storage at 18 °C and 4 °C.
2.5. WWTP sampling
WWTP A was selected for monitoring as it has open channels for
easy sampling of both inﬂuent and efﬂuent wastewater in a time- and
volume proportional manner. It was also of sufﬁcient size (PE
105,847) such that the daily number of pulses of the studied
micropollutants enabled a fair comparison of the two composite sam-
pling modes. Inﬂuent wastewater was sampled after primary screens
and grit removal, but before primary sedimentation. Efﬂuent wastewa-
ter was collected after humus tank sedimentation. Sampling campaigns
were conducted during December 2014 (inﬂuent) and January 2015
(efﬂuent). These campaigns consisted of 8 d composite sampling (Mon-
day to Monday). Time paced and volume paced composites were col-
lected using ISCO 3700 portable samplers (RS Hydro, Worcestershire,
UK). For time paced composites, a 10 mL (±9% RSD - Table S3) aliquot
of wastewater was collected and deposited into 1 L polypropylene bot-
tles every 15min (10 samples per bottle). For volume paced composites
10 mL aliquots were collected once a pre-set of volume of wastewater
had passed. This volume was estimated such that the same number of
sub-samples as the time composite sampler (96) were collected
throughout a 24 h period (average collection frequency = 15 min).
For example, an expected daily ﬂow of 40,000 m3 would result in a
10 mL sample collected every 416.7 m3. The frequency of collection
here would therefore change in response to variations in wastewater
ﬂow (range = 8.9–23.8 min). Flow/volume measurements were made
using an ISCO 2150 ﬂow meter (RS Hydro, Worcestershire, UK;
error = ±2%) coupled to the composite sampler. The ﬂow sensor was
mounted onto a stainless steel slab (35 × 57 cm), lowered and aligned
in the centre of the wastewater stream. Daily ﬂows determined by the
portable ﬂowmeter were within ±9% of that determined by the onsite
ﬂow meter (Table S4). The 24 h period of sampling each day ran from
08:00 h to 08:00 h the following day. On day one of each sampling cam-
paign (Monday) a further sampler was used to collect hourly grab sam-
ples (500mL). The cavity of all samplers were packedwith ice to ensure
collected samples were cooled and stored b4 °C until collection. Sam-
ples were then transferred to the laboratory on ice to maintain a tem-
perature of 4 °C and processed immediately.
3. Results and discussion
3.1. Loss of micropollutants to polypropylene sampler bottles
Micropollutants can be lost during sample collection due to sorption
onto the surface of sampler containerswithin composite samplers. Poly-
propylene was investigated as it is considered the most widely used
sampler bottle material as it is the standard conﬁguration when com-
posite samplers are purchased. Furthermore, it is typically the sampler
bottle material of on-site samplers whose primary focus is not for mon-
itoring micropollutants. These on-site samplers are essential for many
researchers who do not have their own equipment or direct access to
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micropollutants representing a broad range of physico-chemical behav-
iours to polypropylene bottles was investigated in deionisedwater. This
was conducted at both 18 and 4 °C as temperature is known to inﬂuence
the sorption behaviour of all organic micropollutants (Ren et al., 2007).
To determine the signiﬁcance of ﬁndings, those outside a tolerance limit
of ±20% of the starting concentration (time 0) were considered signif-
icant. This approach has been used previously by other authors studying
the stability of micropollutants (Hillebrand et al., 2013; Llorca et al.,
2014), and it outweighs the variability of the analytical method which
is typically b10% (Petrie et al., 2016b).
No signiﬁcant changes were found to the concentration of the ma-
jority of studied micropollutants in deionised water following storage
in polypropylene bottles for 24 h at both 18 and 4 °C (Table 1; Table
S5). This supports ﬁndings by Palmgrén et al. (2006) who noted no sig-
niﬁcant losses (N20%) of naproxen, atenolol, metoprolol and proprano-
lol in water stored at 37 or 3 °C for 270 min. Of the 90 micropollutants
investigated, only tamoxifen showed a signiﬁcant change in concentra-
tion. Following 24 h storage in deionised water, tamoxifen reduced to
31 and 34% of the initial concentration at 18 and 4 °C, respectively.
This is could be a result of its comparatively high hydrophobicity (log
Kow = 6.3 – US EPA, 2015). However, other micropollutants with a
greater log KOW (e.g., atorvastatin) were studied and did not behave
similarly. This suggests the mechanisms which govern uptake are com-
plex and cannot be described using individual chemical properties inde-
pendently. Other bottle materials such as polytetraﬂuoroethylene or
glass may need to be considered to avoid its loss and other similarly be-
having compounds during sample collection. For example,
polytetraﬂuoroethylene liners could be applied to existing polypropyl-
ene sampler bottles (Lapen et al., 2008).
3.2. Micropollutant stability in collected efﬂuent wastewaters
The stability ofmicropollutants in collected efﬂuentwastewaterwas
assessed from twoWWTPs utilising different treatment technologies. In
efﬂuentwastewater, severalmicropollutantswere found to change con-
centration by more than ±20% over 24 h at 18 °C. A total of 23 (26%)
and 20 (22%) of 90 studied micropollutants were outside this range
for efﬂuent from WWTP A and B, respectively (Table S6). Cooling the
sample to 4 °C reduced degradation such that only the concentrations
of 6 micropollutants were considered to have changed substantially in
both efﬂuents after 24 h (WWTP A – benzophenone-3, methylparaben,
acetaminophen, cetirizine, ﬂuoxetine, norﬂuoxetine and WWTP B –
benzophenone-3, methylparaben, ethylparaben, propylparaben, 17β-
estradiol, acetaminophen). Improved stability of micropollutants in ef-
ﬂuent wastewater at 4 °C over short time periods (i.e., 24 h) is in agree-
ment with ﬁndings by Hillebrand et al. (2013). However, it should be
noted that somemicropollutants considered not to be stable in efﬂuent
were different to those found not to be stable in inﬂuent wastewater
(despite having similar pH 7.4–7.7) (Table S6). Therefore the stability
of target micropollutants in the speciﬁc matrix to be monitored should
be investigated prior to any sampling campaign.
Several authors have proposed the addition of a chemical additive
(e.g., NaN3) or acidiﬁcation to pH 2 to help stabilise micropollutants
by inhibiting biological activity (Vanderford et al., 2011; Hillebrand et
al., 2013). Here, the addition of NaN3 at 1 g L−1 resulted in numerous
micropollutants failing the stability test (Table 1; Table S7). NaN3 is
thought to induce chemical changes to some micropollutants such as
bezaﬁbrate, cloﬁbric acid, sertraline and diuron (Hillebrand et al.,
2013). Chefetz et al. (2006) noted a nucleophilic aromatic substitution
reaction between theCl atomof atrazine and the azide ion.Most notably
in this study, NaN3 resulted in the loss of the deuterated surrogate of
heroin (heroin-D9) in most samples. This is despite deuterated surro-
gates being added immediately prior to SPE. It has also been considered
unsuitable for the stabilisation of atenolol, N,N-Diethyl-meta-toluamide
and ﬂuoxetine (Vanderford et al., 2011). It should also be noted thatseveral micropollutants which do not have their own deuterated inter-
nal standard available had recoveries of N150% (Table 1). This could be
an artefact of SPE extraction due to differences in behaviour of the
micropollutant and the internal standard used for quantiﬁcation. There-
fore sampling strategies need consideration during the development
and validation of multi-residue analytical methods. Furthermore, the
use of NaN3 in the ﬁeld is controversial due to its high toxicity.
Acidiﬁcation to pH 2 was hypothesised to be the best way of
stabilising micropollutants in wastewater. However, it should be
noted that adjustment of pH can inﬂuence the partitioning of some
micropollutants between liquid and solid phases of wastewater matri-
ces (Petrovic, 2014). Therefore prior to analysis pH was readjusted to
the original pH of 7.5 (this was also the pH required for the SPEmethod
applied here). Samples were mixed for 30 min because equilibrium fol-
lowing spiking environmental matrices with organic micropollutants is
usually achieved within this time period (Ternes et al., 2004), and as-
sumed to be instantaneous (Fernandez-Fontaina et al., 2013). Neverthe-
less, following pH adjustments several micropollutants showed an
apparent concentration change of N20% (Table S8). Similar ﬁndings
were found for inﬂuent wastewater and were most notable for sulfa-
methoxazole which was not detected in most pH adjusted samples. It
is suspected that partitioning equilibrium similar to starting conditions
were not re-established. This could be improved for some
micropollutants if sample extraction can be performed at pH 2 (e.g.,
see Baker and Kasprzyk-Hordern, 2011), and internal standards used
for quantiﬁcation were spiked prior to sample ﬁltration to account for
changes to partitioning. However, such an approach would result in
total concentration (aqueous + particulate phases) being obtained
over the aqueous concentration.
Overcoming stability issues associated with composite sampling for
the multi-residue determination of micropollutants may require an in-
tegrated approach to sample collection. For example, multi-bottle sam-
pling could be applied such that more than one 24 h composite sample
is collected by the same automated sampler; one stored at 4 °C, another
at pH 2 (and 4 °C). Admittedly this would not be resource efﬁcient as
analysis time and costs would effectively double. Therefore trade-offs
may be required when selecting an appropriate stabilisationmethod(s)
for the multi-residue determination of micropollutants in wastewater.
In future studies such decisions must be made following stability tests
of the micropollutants to be studied using site speciﬁc matrix as no ge-
neric stabilisation method could be established.
3.3. Suitability of time paced composite sampling for monitoring
micropollutants in efﬂuent wastewater
Themost commonway of collecting a composite sample is in a time
proportional manner. A number of studies adopt a default sampling fre-
quency of 15min (Lishman et al., 2006; Morasch et al., 2010; Nagarnaik
et al., 2010; Reungoat et al., 2010; Golovko et al., 2014; Vuori et al.,
2014; Mackuľak et al., 2015), which is typical for environmental appli-
cations. This is also the lowest sampling frequency which can be practi-
cally applied when using portable samplers (i.e., not connected to an
external power supply). However, Ort et al. (2010) used a model to
show that this sampling approach for inﬂuent wastewater is biased
even at a high number of pulses per day (e.g., 10,000 p d−1). Sampling
errors of N20% were noted and can be attributed to the dynamic nature
of wastewater ﬂow andmicropollutant concentration. This error can be
reduced by sampling in a volume- or ﬂow-proportional manner. Error
distributions were unbiased and b20% for both these methods at
≥100p d−1 whilst at sampling frequencies of 15 min (Ort et al., 2010).
For themajority ofmicropollutants studied and detected here, the num-
ber of pulses are estimated to be N100 p d−1. However, it is unknown if
time-paced composite sampling can provide similar information to vol-
ume-paced sampling for efﬂuent wastewater.
A total of 90 micropollutants were monitored over 8 d resulting in
720 data points for comparison. Of these 720 data points, 530 were
Table 1
Loss of micropollutants in deionised water and collected efﬂuent wastewater stored at 4 °C, 4 °C + pH 2 and 4 °C + NaN3 in polypropylene bottles over a 24 h time period (n = 2).
Underlined values show those out with ±20% signiﬁcance level.
Micropollutant class Micropollutant Concentration relative to t = 0 after 24 h storage (%)
H2O WWTP A efﬂuent WWTP B efﬂuent
4 °C 4 °C 4 °C +
pH 2
4 °C +
NaN3
4 °C 4 °C +
pH 2
4 °C +
NaN3
UV ﬁlters Benzophenone-1 109 92 118 123 98 61 110
Benzophenone-2 106 99 68 90 95 64 70
Benzophenone-3 95 65 50 81 78 60 122
Benzophenone-4 111 104 107 101 102 102 102
Parabens Methylparaben 98 65 109 90 48 96 76
Ethylparaben 99 80 113 90 65 93 94
Propylparaben 106 88 90 88 75 81 95
Butylparaben 104 80 101 100 93 102 131
Plasticizer Bisphenol-A 95 106 171 82 116 134 91
Steroid estrogens E1 102 101 97 107 93 94 143
E2 91 86 90 89 35 97 35
EE2 93 106 104 104 110 112 120
Antibacterials/antibiotics Sulfasalazine 89 96 82 133 91 77 111
Clarithromycin 83 86 79 91 100 74 129
Azithromycin 87 85 41 103 89 60 256
Trimethoprim 105 81 17 146 102 22 215
Sulfamethoxazole 101 88 b1 90 93 3 105
Triclosan 91 – – – – – –
Hypertension Valsartan 105 107 63 92 99 87 92
Irbesartan 115 96 89 82 89 50 77
Lisinopril 103 84 60 167 101 49 142
NSAIDs Ketoprofen 97 106 98 101 92 92 93
Ibuprofen 100 102 108 97 83 105 95
Naproxen 98 100 92 86 95 100 102
Diclofenac 92 103 45 86 89 75 91
Acetaminophen 100 15 71 59 20 111 83
Lipid regulators Bezaﬁbrate 101 104 101 103 101 94 104
Atorvastatin 100 84 32 97 89 69 86
Antihistamines Fexofenadine 85 104 50 82 101 89 95
Cetirizine 116 138 79 158 118 67 91
Diabetes Metformin 100 100 91 95 98 96 93
Gliclazide 101 98 88 68 85 72 52
Cough suppressant Pholcodine 10 102 74 65 86 65 55
Beta-blocker Atenolol 98 93 102 94 99 96 103
Metoprolol 99 96 101 95 92 96 98
Propranolol 99 94 104 103 99 104 99
H2 receptor agonists Ranitidine 103 86 12 99 95 54 91
Cimetidine 92 82 110 81 91 103 71
X-ray contrast media Iopromide 100 94 100 95 90 91 96
Drug precursor and metabolite Ephedrine/pseudoephedrine 91 90 357 78 102 204 113
Norephedrine 103 86 103 72 92 84 112
Anti-cancer Azathioprine 98 93 99 77 90 84 83
Methotrexate 99 – – – – – –
Ifosfamide 95 100 79 91 99 84 133
Tamoxifen 34 – – – – – –
Anaesthetic and metabolite Ketamine 100 102 101 98 98 100 96
Norketamine 98 97 100 92 97 102 104
Anti-depressants and metabolites Venlafaxine 102 85 114 102 98 108 103
Desvenlafaxine 101 95 92 97 95 98 100
Fluoxetine 102 57 83 56 88 101 83
Norﬂuoxetine 101 59 80 54 83 115 91
Sertraline 94 85 110 63 87 98 85
Mirtazapine 99 93 103 93 101 108 99
Citalopram 95 90 105 91 108 104 104
Desmethylcitalopram 104 98 117 79 87 131 60
Anti-epileptic and metabolites Carbamazepine 100 96 99 96 92 95 95
Carbamazepine10,11-epoxide 99 97 32 92 90 40 83
10,11-Dihydro-10-hydroxycarbamazepine 97 93 93 92 93 94 93
Calcium channel blocker Diltiazem 106 81 149 34 120 480 b1
Hypnotic Temazepam 107 94 92 95 101 96 109
Anti-psychotic Quetiapine 92 98 94 92 100 98 99
Veterinary Tylosin 104 84 68 85 105 96 122
Human indicators and metabolites Creatinine 110 112 101 44 105 141 100
Nicotine 99 111 268 123 92 199 99
Caffeine 98 87 93 88 87 108 110
Cotinine 98 94 98 93 96 103 105
1,7 dimethylxantine 105 89 99 86 94 111 105
Analgaesics and metabolites Morphine 93 113 99 99 108 107 84
Dihydromorphine 95 101 98 107 91 102 38
(continued on next page)
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Table 1 (continued)
Micropollutant class Micropollutant Concentration relative to t = 0 after 24 h storage (%)
H2O WWTP A efﬂuent WWTP B efﬂuent
4 °C 4 °C 4 °C +
pH 2
4 °C +
NaN3
4 °C 4 °C +
pH 2
4 °C +
NaN3
Normorphine 101 95 106 101 104 130 91
Methadone 107 93 112 91 106 117 101
EDDP 95 98 107 101 96 104 102
Codeine 99 98 97 99 93 103 99
Norcodeine 103 92 108 107 97 109 103
Dihydrocodeine 96 91 95 92 99 107 106
Tramadol 98 103 108 103 92 96 92
N-desmethyltramadol 100 81 119 116 99 109 136
O-desmethyltramadol 101 91 102 87 98 101 95
Stimulants and metabolites Amphetamine 102 94 101 112 93 103 119
Methamphetamine 100 98 115 94 99 120 91
MDMA 96 93 107 95 98 96 99
MDA 105 99 105 100 102 107 101
Cocaine 103 94 98 90 91 97 96
Benzoylecgonine 98 102 91 102 101 89 112
Anhydroecgonine methylester 102 120 276 115 87 157 81
Cocaethylene 102 99 107 98 99 108 105
Mephedrone 94 109 103 96 92 101 100
MDPV 103 93 125 123 105 107 112
Opioid and metabolite Heroin 99 81 104 47 84 94 b1
6-acetylmorphine 103 105 79 102 97 57 15
Key: WWTP, wastewater treatment plant; E1, estrone; E2, 17β-estradiol; EE2, 17α-ethinylestradiol; EDDP, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; MDMA, 3,4-
methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-amphetamine; MDPV, methylenedioxypyrovalerone; -, the initial concentration was below the method quantitation
limit for 10 mL extractions (triclosan, b81 ng L−1; methotrexate, b117 ng L−1; tamoxifen, b18 ng L−1).
574 B. Petrie et al. / Science of the Total Environment 579 (2017) 569–578found to be NMQL. During the 8 d sampling period, no signiﬁcant differ-
ence (N20%) in concentration was observed between time-paced and
volume-paced composite sampling for any micropollutant in efﬂuent
wastewater (Table S9). This was in contrast to inﬂuent wastewater
which saw 66 of 471 quantiﬁed micropollutants concentrations in
time-paced composites to be outside a ± 20% tolerance limit of the vol-
ume-paced composite (Table S9). The HRT of theWWTP under investi-
gation (WWTP A) is typically ~8 h considering residence times in
primary sedimentation tanks, open channels, trickling ﬁlters and
humus tanks providing greater mixing. Consequently, intra-day vari-
ability in concentration (calculated from all grab samples collected
throughout the day) was generally lower (Table S10), resulting in sim-
ilar concentration information obtained by time- and volume-paced
composites. This may require further validation for different process
types to ensure these observations can be extrapolated to other
systems.
Interestingly, mean concentrations determined from grab sampling
(n=24, equivalent to a composite samplewith a 1 h sub-sample collec-
tion frequency) were similar to those determined by composite sam-
pling (within ±20%) (Fig. 1A). However, in practical terms if grab
sampling was to be applied, only one sample would be collected per
day during a monitoring study. Therefore the representativeness of
grab sampling will be underpinned by the extent of diurnal concentra-
tion variation. The variation observed throughout 24 hwas different be-
tween micropollutants and appeared independent of number of pulses
(Fig. 1B). To demonstrate, caffeine (N10,000 p d−1) varied in concentra-
tion from 1125 to 18,688 ng L−1 (intra-day concentration variability =
69%, n = 24). In contrast, azithromycin (200 p d−1) ranged from 85 to
148 ng L−1 (intra-day concentration variability=15%, n=24). Similar-
ly carbamazepine (2800 p d−1) varied from 135 to 176 ng L−1 (intra-
day concentration variability = 8%, n = 24). This is in agreement with
Nelson et al. (2011) who noted intra-day concentration variations of
6–8% (n= 24) for carbamazepine in tertiary efﬂuent wastewater. Con-
sequently, of the 24 grab samples collected only three for caffeine
whereas 20 and 21 for azithromycin and carbamazepine provided con-
centrations within ±20% of the composite sample (Fig. 1B). Therefore
collecting one grab sample per day is not suitable for obtaining repre-
sentative information on daily micropollutant concentrations.Nevertheless, as not all WWTPs have samplers permanently installed
(particularly for smaller plants), the possibility of sampling efﬂuent
wastewater using time paced composite samplers over volume or
ﬂow composites is advantageous. This is becauseWWTPs are less likely
to have suitable sites (e.g., easily accessible open channels) for
deploying portable ﬂowmeters to measure efﬂuent discharge and con-
trol sample collection.
3.4. Diurnal changes to the enantiomeric distribution of chiral
micropollutants in efﬂuent wastewater
Due to enantio-speciﬁc toxicity towards exposed aquatic micro-or-
ganisms, it is essential to include analysis of chiral micropollutants at
the enantiomeric level in monitoring studies for accurate environmen-
tal risk assessment. However, there is a paucity of information on tem-
poral changes to the enantiomeric distribution of chiral micropollutants
in efﬂuentwastewaters. Inwastewater, enantiomeric distribution could
vary bothwithin the same day and between different days. This can be a
result of (i) changing HRT (due to changes in ﬂow) within the receiving
sewer and WWTP causing varying degrees of stereo-selective transfor-
mation, or (ii) the direct disposal of non-consumed drugs which
would normally undergo stereo-selective changes when consumed
and metabolised (Emke et al., 2014; Petrie et al., 2016a).
Based on ﬂow data when hourly grab samples were collected, the
variability in WWTP HRT was estimated to range from 6 to 14 h. How-
ever, grab samples (n = 24) showed little change to EF of the studied
chiralmicropollutants (Fig. 2). Fluoxetine showed the greatest variation
throughout the day with EFs ranging from 0.88 to 1.00. This EF denotes
enrichmentwith S-(+)-ﬂuoxetine. This enantiomer is reported to be 10
times more toxic then R-(−)-ﬂuoxetine to both P. promelas (Stanley et
al., 2007) and T. thermophila (De Andrés et al., 2009), illustrating the ne-
cessity of incorporating enantio-selective analysis intomonitoring strat-
egy for environmental risk assessment. Similarly, little change to EFs
was observed between different days. Only MDMA showed temporal
changes to EF, ranging from 0.24 to 0.38 over the 8 d (Fig. 3). In inﬂuent
wastewater the majority of chiral micropollutants showed similar vari-
ability in their enantiomeric distribution both throughout the day and
between different days (Fig. S1; Fig. S2). This suggests that the number
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Fig. 1. Impact of samplingmode on concentration of azithromycin (200 p d−1), carbamazepine (2800 p d−1) and caffeine (N10,000 pd−1) in efﬂuentwastewater over 8 d (A), and hourly
concentration on theﬁrstMonday of the 8 d samplingperiod (B)– the blue shaded area represents the averagehourly concentration of the volume paced 24h composite±20%. Note: grab
sampling in (A) is the average of n= 24 samples from (B) (equivalent to a composite samplewith a 1 h sub-sample collection frequency), and error bars here represent the range of data.
All other error bars represent the standard deviation of the mean. Key: p d−1, pulses per day; ND, not determined.
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Fig. 2.Hourly concentrations and enantiomeric fraction of chiral micropollutants in efﬂuentwastewater on the ﬁrstMonday of the sampling period in January 2015. Key: EF, enantiomeric
fraction; MDMA, 3,4-methylenedioxy-methamphetamine.
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576 B. Petrie et al. / Science of the Total Environment 579 (2017) 569–578of enantio-selective analysis performed could be reduced during a typ-
ical week-long sampling period. Such an approach would be advanta-
geous as several analytical methodologies are often required
(including SPE protocols) to determine a range of chiralmicropollutants
at the enantiomeric level. However, this is not recommended as unpre-
dictable short-term (e.g., daily) changes to enantiomeric distribution
can occur by the direct disposal of unused medication (see ﬂuoxetine
- Fig. S2; Petrie et al., 2016a). Therefore the same resolution of
enantio-selective analysis as more routine achiral (e.g., C18) analytical
methodologies is needed throughout the entire monitoring period.
This will ensure accurate information for environmental risk assess-
ment is attained.
3.5. Recommendations for monitoring micropollutants in efﬂuent wastewater
for regulatory compliance
There is likely to be legislation implemented in the future governing
the discharge of trace organic micropollutants (e.g., pharmaceuticals)
fromWWTPs into the environment. This will put emphasis onmonitor-
ing strategies to ensure representative data are attained to accurately
determine compliance with legislative discharge limits. Currently, sam-
pling efﬂuent wastewater quality for regulatory compliance or consent
often involves the collection of low-frequency grab samples. This ap-
proach has been adopted in several national studies monitoring
micropollutants in treated efﬂuents in both the UK (Gardner et al.,
2012) and across the rest of Europe (Loos et al., 2013). However, consid-
ering the diurnal variability in micropollutant concentration (Fig. 1;0.0
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Fig. 3. Daily concentrations and enantiomeric fraction of chiral micropollutants in efﬂuent w
enantiomeric fraction; MDMA, 3,4-methylenedioxy-methamphetamine.Table S10) and EQS are likely to applicable to annual average concentra-
tions, collecting a sample which can provide accurate concentration in-
formation for a 24 h period or longer is recommended. Such an
approach would provide representative information and be more suit-
able for assessing regulatory compliance. Passive sampling has been con-
sidered for providing estimated time-weighted concentrations for
periods of 7 d or longer. However, this technology has yet to prove itself
for providing accurate concentration information suitable for regulatory
purposes (Jones et al., 2015). Therefore 24 h composite sampling will be
needed formonitoring regulatedmicropollutants in efﬂuentwastewater.
As reported in this manuscript, ensuring the stability of micropollutants
during sample collection is critical for such an approach to be successful-
ly implemented for regulatory purposes. It is expected that chiral
micropollutants will not be regulated at the enantiomeric level in the
short-term. EQS are likely to apply to the sum of all enantiomers for a
given micropollutant. However, the application of enantio-selective
analysis as a complimentary technique where possible will help develop
future legislation to ensure protection of the receiving environment.
4. Conclusions
• Polypropylene, the most common used sampler bottle material, was
suitable for the determination of 89 of the 90 studiedmicropollutants.
Only tamoxifen (log KOW= 6.3) showed signiﬁcant losses of N20% to
sample bottles.
• No generic method could be identiﬁed to stabilise all 90
micropollutants simultaneously during composite sample collection.0.0
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astewater over 8 d in January 2015 collected as 24 h volume paced composites. Key: EF,
577B. Petrie et al. / Science of the Total Environment 579 (2017) 569–578Cooling samples to 4 °C provided the best solution but to stabilise fur-
ther micropollutants, multi-bottle sampling is required to provide ad-
ditional storage conditions (e.g., pH 2). In any case, the stability of
target micropollutants in thematrix to bemonitored should be inves-
tigated prior to any sampling campaign.
• In efﬂuent wastewater, time-paced composites provided similar con-
centrations (within ±20%) to volume-paced composites for the 90
micropollutants over 8 d. Reducing the need to sample efﬂuentwaste-
water in a way which accounts for ﬂow variability is advantageous as
not all WWTPs have sampler compatible ﬂow meters installed on
their premises, or suitable sites for the easy deployment of portable
ones.
• The enantiomeric distribution of chiral micropollutants did not
change for the majority of micropollutants over 8 d. However, short-
term changes may occur as a result of direct disposal. The unpredict-
ability of such events demands similar resolution of enantio-selective
analysis as more routine achiral methods throughout the sampling
period.
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